NPS Pharmaceuticals Inc. (NPSP) said it hasn’t received any overtures from Shire Plc (SHP) or any of the Dublin-based drug company’s representatives about a possible acquisition. Bloomberg News reported May 30 that NPS hadn’t been contacted by Shire, according to a personal familiar with the matter. The Financial Times’ Alphaville website reported on May 30 that Shire has held internal discussions about a possible cash offer for NPS, the Bedminster, New Jersey-based company that makes medicines for rare diseases. Shire has been adding drugs for rare diseases to lessen its dependence on its best-selling pill for attention deficit hyperactivity disorder.
Help employers find you! Check out all the jobs and post your resume.
